No results for ‘’
Global Longlife Hospital and Research Ltd
₹14.60
(3.91%)
Sat, 19 Sept 2026, 05:16 pm
Health Services
Hospital/Nursing Management
24.5KGlobal Longlife Hospital and Research Enterprise Value (EV)
| Particulars | 2022 | 2023 | 2024 |
|---|---|---|---|
| Price to earnings ratio | 24.95 | 0 | 100.21 |
| Price to book ratio | 0.73 | 1.58 | 0.74 |
| Price to sales ratio | 1.94 | 3.03 | 34.48 |
| Price to cash flow ratio | 0 | 0 | 1.64 |
| Enterprise value | 51.17Cr | 53.31Cr | -1.63Cr |
| Enterprise value to EBITDA ratio | 12.53 | 0 | 0 |
| Debt to equity ratio | 0.14 | 0.49 | 0 |
| Return on equity % | 0 | -4.85 | 0.75 |
Global Longlife Hospital and Research Ltd Enterprise Value
The Global Longlife Hospital and Research Ltd Enterprise Value is a key financial metric used by investors to evaluate Global Longlife Hospital and Research Ltd's valuation, profitability, and overall financial performance. Tracking the Global Longlife Hospital and Research Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Global Longlife Hospital and Research Ltd (NSE: , BSE: 543520) is currently trading at ₹14.60, with a market capitalization of ₹15.15Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Global Longlife Hospital and Research Ltd Enterprise Value is essential for fundamental analysis.
Global Longlife Hospital and Research Ltd Enterprise Value Current Value
The current Global Longlife Hospital and Research Ltd Enterprise Value stands at -1.63Cr.
The Global Longlife Hospital and Research Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Global Longlife Hospital and Research Ltd Enterprise Value Historical Trend
The Global Longlife Hospital and Research Ltd Enterprise Value has shown the following historical trend:
- 2024: -1.63Cr
- 2023: 53.31Cr
- 2022: 51.17Cr
The decline in Global Longlife Hospital and Research Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Global Longlife Hospital and Research Ltd Enterprise Value Indicates for Investors
The Global Longlife Hospital and Research Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Global Longlife Hospital and Research Ltd.
Global Longlife Hospital and Research Ltd Enterprise Value Analysis Summary
The Global Longlife Hospital and Research Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Global Longlife Hospital and Research Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Global Longlife Hospital and Research Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.